InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,628.34
(
0.78%
)
US TECH 100
19,837.20
(
0.81%
)
Dow Jones
40,062.78
(
0.78%
)
Brent Oil
85.00
(
-0.14%
)
Bitcoin
58,081.56
(
1.28%
)
Post# of 464046
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

PeterKarol

Send PM Follow Ignore
Followers 19
Posts 544
Boards Moderated 0
Alias Born 07/07/2016

PeterKarol

Re: seventhwave post# 123422

Friday, 10/06/2017 9:52:48 PM

Friday, October 06, 2017 9:52:48 PM

Post# of 464046
Ultimately FDA classification is what matters. If they think that models used by AVXL in this "general" epilepsy are of different etiology than let's say Rett then things are settled on those as two separate to be approved.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AVXL News
More AVXL News
InvestorsHub NewsWire

Cannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing • BLO • Jul 11, 2024 8:21 AM

ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • ECGI • Jul 10, 2024 8:30 AM

Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM

Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM

Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM

Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM

Start posting your company's news
Only $200 per official company press release!